Aluminium Involvement in Neurotoxicity
The aetiology of neurodegenerative diseases (ND) seems to involve susceptibility genes and environmental factors. Toxic metals are considered major environmental pollutants. Following our study of a case of multiple sclerosis (MS) improvement due to removal of aluminium (Al) and other toxic metals,...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/758323 |
id |
doaj-e2ae405eacaa4de980b40c2a9ab9b0c1 |
---|---|
record_format |
Article |
spelling |
doaj-e2ae405eacaa4de980b40c2a9ab9b0c12020-11-24T20:55:07ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/758323758323Aluminium Involvement in NeurotoxicityAlessandro Fulgenzi0Daniele Vietti1Maria Elena Ferrero2Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Luigi Mangiagall, 31, 20133 Milano, ItalyDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Luigi Mangiagall, 31, 20133 Milano, ItalyDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Luigi Mangiagall, 31, 20133 Milano, ItalyThe aetiology of neurodegenerative diseases (ND) seems to involve susceptibility genes and environmental factors. Toxic metals are considered major environmental pollutants. Following our study of a case of multiple sclerosis (MS) improvement due to removal of aluminium (Al) and other toxic metals, we have examined the possible relationship between Al intoxication and ND. We used the slow intravenous treatment with the chelating agent EDTA (calcium disodium ethylene diamine tetraacetic acid) (chelation test) to remove Al and detected it in the urine collected from the patients for 12 hours. Patients affected by MS represented 85.6% of total ND. Al was present in 44.8% of cases comprehensive of ND and healthy patients. Al levels were significantly higher in ND patients than in healthy subjects. We here show that treatment of patients affected by Al burden with ten EDTA chelation therapies (EDTA intravenous administration once a week) was able to significantly reduce Al intoxication.http://dx.doi.org/10.1155/2014/758323 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alessandro Fulgenzi Daniele Vietti Maria Elena Ferrero |
spellingShingle |
Alessandro Fulgenzi Daniele Vietti Maria Elena Ferrero Aluminium Involvement in Neurotoxicity BioMed Research International |
author_facet |
Alessandro Fulgenzi Daniele Vietti Maria Elena Ferrero |
author_sort |
Alessandro Fulgenzi |
title |
Aluminium Involvement in Neurotoxicity |
title_short |
Aluminium Involvement in Neurotoxicity |
title_full |
Aluminium Involvement in Neurotoxicity |
title_fullStr |
Aluminium Involvement in Neurotoxicity |
title_full_unstemmed |
Aluminium Involvement in Neurotoxicity |
title_sort |
aluminium involvement in neurotoxicity |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2014-01-01 |
description |
The aetiology of neurodegenerative diseases (ND) seems to involve susceptibility genes and environmental factors. Toxic metals are considered major environmental pollutants. Following our study of a case of multiple sclerosis (MS) improvement due to removal of aluminium (Al) and other toxic metals, we have examined the possible relationship between Al intoxication and ND. We used the slow intravenous treatment with the chelating agent EDTA (calcium disodium ethylene diamine tetraacetic acid) (chelation test) to remove Al and detected it in the urine collected from the patients for 12 hours. Patients affected by MS represented 85.6% of total ND. Al was present in 44.8% of cases comprehensive of ND and healthy patients. Al levels were significantly higher in ND patients than in healthy subjects. We here show that treatment of patients affected by Al burden with ten EDTA chelation therapies (EDTA intravenous administration once a week) was able to significantly reduce Al intoxication. |
url |
http://dx.doi.org/10.1155/2014/758323 |
work_keys_str_mv |
AT alessandrofulgenzi aluminiuminvolvementinneurotoxicity AT danielevietti aluminiuminvolvementinneurotoxicity AT mariaelenaferrero aluminiuminvolvementinneurotoxicity |
_version_ |
1716792539416100864 |